Cline Scientific AB (OSTO:CLINE B) ROCE %: 2.68% (As of Dec. 2023)


OSTO:CLINE B Cline Scientific AB OSTO:CLINE B
4 GF Score
Price kr0.07
View Full Analysis

What is Cline Scientific AB ROCE %?

Cline Scientific AB OSTO:CLINE B 4 ROCE % is 2.68% as of Dec. 2023. GuruFocus rates OSTO:CLINE B with a GF Score™ of 4/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Cline Scientific AB's annualized ROCE % for the quarter that ended in Dec. 2023 was 2.68%.

Cline Scientific AB  (OSTO:CLINE B) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Cline Scientific AB ROCE % Related Terms

Cline Scientific AB ROCE % Historical Data

* Premium members only.

The historical data trend for Cline Scientific AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cline Scientific AB ROCE % Chart

Cline Scientific AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only -40.54 -23.08 -24.60 -12.93 -15.87

Cline Scientific AB Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.63 -31.39 2.85 -40.37 2.68
OSTO:CLINE B
4GF Score
Cline Scientific AB OSTO:CLINE B
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cline Scientific AB ROCE % Calculation

Cline Scientific AB's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-3.109/( ( (18.817 - 0.542) + (22.721 - 1.804) )/ 2 )
=-3.109/( (18.275+20.917)/ 2 )
=-3.109/19.596
=-15.87 %

Cline Scientific AB's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=0.48/( ( (14.974 - 0.065) + (22.721 - 1.804) )/ 2 )
=0.48/( ( 14.909 + 20.917 )/ 2 )
=0.48/17.913
=2.68 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 2.68% mean?
Cline Scientific AB (OSTO:CLINE B) has a ROCE % of 2.68% as of Dec. 2023.
Is Cline Scientific AB's ROCE % too high?
Cline Scientific AB's current ROCE % is 2.68%. Overall, Cline Scientific AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Cline Scientific AB's ROCE % compare to VRTX and REGN?
Cline Scientific AB's ROCE % of 2.68% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Cline Scientific AB's current ROCE % is 2.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cline Scientific AB stock overvalued right now?
Cline Scientific AB (OSTO:CLINE B) has a current ROCE % of 2.68%. The current ROCE % is 2.68%. Cline Scientific AB's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Cline Scientific AB (OSTO:CLINE B), the current ROCE % is 2.68% as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cline Scientific AB Business Description

Address Vastra Gotalands Lan, 2C Argongatan, Molndal, SWE, 43153
Cline Scientific AB develops and markets products for biomedical research based on proprietary nanotechnology. Its products include unique surfaces for use in stem cell & cancer research and customized nanoparticles for use in biomedical applications.
4GF Score

Get the complete analysis for OSTO:CLINE B

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.07
Price